Evidence map›Paper›PMID 42143561›Full record

Observational studyAmerican journal of industrial medicine2026

Asbestos-Related Respiratory Diseases in Spain: Insights From the Spanish Registry.

Galo Granados, María-Jesús Cruz, Isabel Urrutia-Landa, Olaia Bronte-Moreno, Sandra Dorado-Arenas, Carmen Diego-Roza, Irene Nieto-Codesido, Santiago Rodríguez-Segade-Alonso, Raquel Ruiz-Ferreras, Ana Fernández-Tena and 19 more

Abstract readObservational Study
In one paragraph

Observational study in American journal of industrial medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Galo GranadosDepartment of Respiratory Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-1902-1835
María-Jesús CruzDepartment of Respiratory Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0001-9759-5466
Isabel Urrutia-LandaGaldakao-Usansolo Hospital, Galdakao, Vizcaya, Spain.ORCID 0000-0002-6827-6885
Olaia Bronte-MorenoGaldakao-Usansolo Hospital, Galdakao, Vizcaya, Spain.ORCID 0000-0002-8161-4447
Sandra Dorado-ArenasGaldakao-Usansolo Hospital, Galdakao, Vizcaya, Spain.ORCID 0000-0002-0798-2153
Carmen Diego-RozaComplexo Hospitalario Universitario de Ferrol, La Coruña, Spain.
Irene Nieto-CodesidoComplexo Hospitalario Universitario de Ferrol, La Coruña, Spain.ORCID 0000-0002-4257-4817
Santiago Rodríguez-Segade-AlonsoComplexo Hospitalario Universitario de Ferrol, La Coruña, Spain.ORCID 0000-0002-5944-8454
Raquel Ruiz-FerrerasComplexo Hospitalario Universitario de Ferrol, La Coruña, Spain.
Ana Fernández-TenaSilicosis National Institute, Oviedo, Asturias, Spain.ORCID 0000-0002-5944-4023
Rosirys Guzmán-TaverasSilicosis National Institute, Oviedo, Asturias, Spain.ORCID 0000-0002-2224-1679
Aida Quero-MartínezSilicosis National Institute, Oviedo, Asturias, Spain.
María Encarnación Barroso-MedelSanta Lucia Hospital, Cartagena, Murcia, Spain.ORCID 0009-0003-2422-0243
Eva María Rosillo-HernándezDr. Balmis University General Hospital, Alicante, Spain.
Antonio Santa Cruz-SiminianiSanta Lucia Hospital, Cartagena, Murcia, Spain.
Marta Hernández-OlivoSanta Lucia Hospital, Cartagena, Murcia, Spain.ORCID 0000-0002-5490-4369
Cristina Martínez-GonzálezAsturias Central University Hospital, Oviedo, Spain.ORCID 0000-0002-0369-4920
Pilar CebolleroNavarra University Hospital, Pamplona, Spain.ORCID 0000-0002-6796-5603
Belén Marín-MartínezNavarra University Hospital, Pamplona, Spain.
Tamara Gutiérrez-UrraNavarra University Hospital, Pamplona, Spain.
Pablo Sanchez-SalcedoNavarra University Hospital, Pamplona, Spain.ORCID 0000-0001-5690-4947
Fernando Romero-ValeroCádiz Hospital, Cádiz, Spain.
Sara Calero PardoGetafe University Hospital, Madrid, Spain.ORCID 0009-0000-5719-0835
Federico Madrid-SanMartinUnidad de referencia EEPP de Levante-ASEPEYO, Valencia, Spain.
Jaime Signes CostaUniversity Clinical Hospital, INCLIVA, Valencia, Spain.ORCID 0000-0002-8221-6045
Enric Burés-SalesUniversity Clinical Hospital, INCLIVA, Valencia, Spain.
Mª Belén Safont-MuñozUniversity Clinical Hospital, INCLIVA, Valencia, Spain.
Juan José Ruíz-CubillánMarqués de Valdecilla University Hospital, Santander, Spain.ORCID 0000-0002-7251-0232
Jaume Ferrer-SanchoDepartment of Respiratory Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0001-6616-0670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough many Spanish workers have been exposed to asbestos, asbestos-related diseases (ARD) have not been widely reported in this country. The aim of the present study was to analyze the data recorded in the Spanish Registry of asbestos-derived diseases.

methodsA retrospective observational study was conducted based on data reported between September 19, 2018, and May 15, 2023, covering 11 Spanish autonomous communities. Variables included demographic data, type of exposure, symptoms, pulmonary function tests, radiological studies, and initial and follow-up diagnoses.

resultsOne thousand seven hundred and twenty-one cases were reported, with a mean age of 75.2 years. The majority were men (96.7%) and were smokers or former smokers (78.8%). Occupational exposure accounted for 98.3% of cases, mainly in the naval sector (70%). Pleural plaques were the most prevalent diagnosis (82.1%), followed by asbestosis (14.9%) and lung cancer (11%). During follow-up, 181 new diagnoses were made, including lung cancer (23.76%) and mesothelioma (11.6%). The overall mortality rate was 13.4%, with lung cancer being the leading cause of death.

conclusionsThis study provides a first overview of ARD in Spain. The most notable findings are the importance of shipyards as a source of exposure, the predominance of pleural plaques and the number of new diagnoses made during the follow-up, and the need for continuous surveillance and early diagnosis to mitigate asbestos-related adverse effects.

Indexed as

AsbestosAsbestosisLung NeoplasmsOccupational DiseasesOccupational ExposureAgedAged, 80 and overFemaleHumansMaleMesotheliomaMiddle AgedRegistriesRetrospective StudiesSpainAsbestosasbestoslung cancermesotheliomaoccupational respiratory diseasespleural plaques

Identifiers

PMID42143561
PMCPMC13350336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.